Francis R. Cano's most recent trade in Dynavax Technologies Corp. was a trade of 28,500 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 11, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Dynavax Technologies Corp. | Francis R. Cano | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2025 | 28,500 | 28,500 | - | - | Stock Option (Right to Buy) | |
| Dynavax Technologies Corp. | Francis R. Cano | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2025 | 5,758 | 42,663 (0%) | 0% | 0 | Common Stock | |
| Dynavax Technologies Corp. | Francis R. Cano | Director | Sale of securities on an exchange or to another person at price $ 11.93 per share. | 31 May 2024 | 3,615 | 36,905 (0%) | 0% | 11.9 | 43,127 | Common Stock |
| Dynavax Technologies Corp. | Francis R. Cano | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2024 | 22,500 | 22,500 | - | - | Stock Option (Right to Buy) | |
| Dynavax Technologies Corp. | Francis R. Cano | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.90 per share. | 23 May 2024 | 7,500 | 44,405 (0%) | 0% | 5.9 | 44,250 | Common Stock |
| Dynavax Technologies Corp. | Francis R. Cano | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 May 2024 | 7,500 | 0 | - | - | Stock Option (Right to Buy) | |
| Dynavax Technologies Corp. | Francis R. Cano | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2024 | 5,357 | 36,905 (0%) | 0% | 0 | Common Stock | |
| Dynavax Technologies Corp. | Francis R. Cano | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 11.39 per share. | 23 May 2024 | 3,885 | 40,520 (0%) | 0% | 11.4 | 44,250 | Common Stock |
| Dynavax Technologies Corp. | Francis R. Cano | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2023 | 22,500 | 22,500 | - | - | Stock Options (Right to Buy) | |
| Dynavax Technologies Corp. | Francis R. Cano | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2023 | 5,357 | 31,548 (0%) | 0% | 0 | Common Stock | |
| Dynavax Technologies Corp. | Francis R. Cano | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.97 per share. | 08 Aug 2022 | 15,000 | 35,834 (0%) | 0% | 5.0 | 74,550 | Common Stock |
| Dynavax Technologies Corp. | Francis R. Cano | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Aug 2022 | 15,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Dynavax Technologies Corp. | Francis R. Cano | Director | Sale of securities on an exchange or to another person at price $ 17.17 per share. | 08 Aug 2022 | 15,000 | 20,834 (0%) | 0% | 17.2 | 257,550 | Common Stock |
| Dynavax Technologies Corp. | Francis R. Cano | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2022 | 22,500 | 22,500 | - | - | Option (Right to Buy) | |
| Dynavax Technologies Corp. | Francis R. Cano | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2022 | 5,357 | 5,357 | - | - | Restricted Stock Unit | |
| Dynavax Technologies Corp. | Francis R. Cano | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.50 per share. | 24 Aug 2021 | 4,167 | 20,834 (0%) | 0% | 4.5 | 18,752 | Common Stock |
| Dynavax Technologies Corp. | Francis R. Cano | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Aug 2021 | 4,167 | 0 | - | - | Warrant (Right to Buy) | |
| Dynavax Technologies Corp. | Francis R. Cano | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 May 2021 | 25,000 | 25,000 | - | - | Option (Right to Buy) | |
| Biomerica Inc. | Francis R. Cano | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 10 Dec 2020 | 20,000 | 146,736 (1%) | 0% | - | Common Stock | |
| Biomerica Inc. | Francis R. Cano | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Dec 2020 | 20,000 | 175,000 | - | - | Non-qualified stock option |